(Q40737208)

23 September 2017

title

Rotavirus Vaccines: Current Controversies and Future Directions (English)

1 reference

23 September 2017

1 reference

Coffin SE

1

1 reference

23 September 2017

language of work or name

1 reference

1 February 2000

1 reference

Current infectious disease reports

23 September 2017

published in

1 reference

23 September 2017

volume

2

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

68-72

1 reference

The Clinical Features of Infantile Gastroenteritis due to Rotavirus

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-000-0090-0

Host factors associated with protection against rotavirus disease: the skies are clearing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-000-0090-0

Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-000-0090-0

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-000-0090-0

Protection against Rotavirus Disease after Natural Rotavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-000-0090-0

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

21 January 2018

1 reference

12 December 2020

Cost-effectiveness analysis of a rotavirus immunization program for the United States

1 reference

12 December 2020

The Protective Effectiveness of Natural Rotavirus Infection in an American Indian Population

1 reference

12 December 2020

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants

1 reference

12 December 2020

Cost-effectiveness analysis of a rotavirus immunization program for the United States

1 reference

12 December 2020

A one-year virological survey of acute lntussusception in childhood

1 reference

12 December 2020

Characterization of human rotavirus genotype P[8]G5 from Brazil by probe-hybridization and sequence

1 reference

12 December 2020

Relative importance of rotavirus-specific effector and memory B cells in protection against challenge.

1 reference

12 December 2020

Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children

1 reference

12 December 2020

Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine

1 reference

12 December 2020

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine

1 reference

12 December 2020

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Rotavirus infection in infants as protection against subsequent infections

1 reference

12 December 2020

A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population

1 reference

12 December 2020

Clinical, laboratory, and epidemiologic features of a viral gastroenteritis in infants and children

1 reference

12 December 2020

Human rotavirus infection in infants and young children with intussusception

1 reference

12 December 2020

Lack of an apparent association between intussusception and wild or vaccine rotavirus infection

1 reference

12 December 2020

Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity

1 reference

12 December 2020

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

1 reference

12 December 2020

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

12 December 2020

The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden

1 reference

12 December 2020

Trends in hospitalization and mortality from rotavirus disease in New Zealand infants

1 reference

12 December 2020

Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine

1 reference

12 December 2020

Impact of rotavirus infection at a large pediatric hospital

1 reference

12 December 2020

Detection and characterization of novel rotavirus strains in the United States.

1 reference

12 December 2020

Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code.

1 reference

12 December 2020

Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

A two-part study of the aetiological role of rotavirus in lntussusception

1 reference

12 December 2020

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

12 December 2020

Human rotavirus and intussusception

1 reference

12 December 2020

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

1 reference

12 December 2020

Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies

1 reference

12 December 2020

Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries

1 reference

12 December 2020

Rotaviruses: immunological determinants of protection against infection and disease.

1 reference

12 December 2020

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

12 December 2020

An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group

1 reference

12 December 2020

10.1007/S11908-000-0090-0

Identifiers

DOI

1 reference

23 September 2017

1 reference